Business The Jab Of Life: Covaxin’s Success Proves Bharat Biotech Was On Right Path BY Outlook Web Desk
miscellaneous Second COVID-19 Vaccine Dose Of 18 Lakh People Overdue In West Bengal BY Outlook Web Desk
Making A Difference UK To Add Covaxin To List Of Approved Covid-19 Vaccines For International Travellers BY Outlook Web Desk
Making A Difference US To Allow Vaccinated Foreigners To Enter From Nov 8: What It Means For Indian Travellers BY Outlook Web Desk
National Bharat Biotech’s US Partner Seeks Approval For Use Of Covaxin In Children BY Outlook Web Desk
National Covaxin Gets WHO Nod For Emergency Use: What That Means For Indian Travelers BY Outlook Web Desk
National Covaxin: WHO Panel Recommends Emergency Use Listing Status For Bharat Biotech's Covid Vaccine BY Outlook Web Desk
National Covaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 Months BY Outlook Web Desk
National Australia Recognises Covaxin: All Countries That Have Approved Bharat Biotech's Covid-19 Vaccine BY Outlook Web Desk
National Covaxin: 7 Countries Allowing Entry To Indians Vaccinated With Bharat Biotech's Covid-19 Shot BY Outlook Web Desk
Making A Difference Covid-19 Vaccine: Oman Approves Bharat Biotech's Covaxin Under New Travel Rules BY Outlook Web Desk
National 100 Crore Shots: How India Achieved Covid-19 Vaccination Milestone In 280 Days BY Outlook Web Desk
National WHO Technical Group To Meet On Oct 26 To Consider EUL Of Bharat Biotech’s Covaxin BY Outlook Web Desk
National Covid Expert Panel Approves Bharat Biotech's Covaxin For Children Between 2-18 BY Outlook Web Desk
National Over 3.86 Crore People Yet To Get Complete Vaccination Within Stipulated Time: Govt BY Outlook Web Desk
National Mixing Covaxin and Covishield: India's Drug Authority Gives Nod To Study, Trials BY Outlook Web Desk
National Combination Of Covishield, Covaxin Better Than 2 Doses Of Same Vaccine: ICMR Study BY Outlook Web Bureau
National Revised Covishield Monthly Production Likely To be More Than 120 Million, Covaxin 58 Million: Health Minister BY Outlook Web Desk
National Covaxin Provides Protection Against Delta Plus Covid Variant: ICMR Study BY Outlook Web Bureau